Skip to main content

Tenax Therapeutics Inc (TENX) Stock

Tenax Therapeutics Inc Stock Details, Movements and Public Alerts

Stock Details

Tenax Therapeutics Inc (TENX), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $13.84. Over the past 52 weeks, it has ranged between $4.63 and $18.38. This places the current price at 75.3% of its 52-week high and 198.9% above its 52-week low. Recent trading volume was recorded at 273,584. The 14-day Relative Strength Index (RSI) stands at 62.77, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $13.13 by 5.41%. Similarly, it is above its 200-day moving average of $8.54 by 62.06%. The MACD histogram is 0.13, indicating bullish momentum (MACD Line: -0.24, Signal Line: -0.36).

52-Week Range

$18.38 - $4.63

-24.70% from high · +198.92% from low

Avg Daily Volume

306,164

20-day average

100-day avg: 215,495

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

0.30

PEG Ratio

1.44

Reasonably valued

Price to Book

0.90

EV/EBITDA

-0.14

EPS (TTM)

-$0.74

Price to Sales

414.72

Beta

1.44

Similar volatility to market

Q:How is TENX valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is TENX's risk profile compared to the market?
With a beta of 1.44, Tenax Therapeutics Inc is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 0.90 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-19,486,000

Return on Equity

-55.60%

Return on Assets

-35.10%

Revenue Growth (YoY)

0.00%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is TENX's business model?
Profitability metrics are not available for this stock.
Q:What are TENX's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$86.4M

Revenue (TTM)

$0

Revenue/Share (TTM)

$0.00

Shares Outstanding

6.24M

Book Value/Share

$2.29

Asset Type

Common Stock

Q:What is TENX's market capitalization and position?
Tenax Therapeutics Inc has a market capitalization of $86.4M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 6.24M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
Q:How does TENX's price compare to its book value?
Tenax Therapeutics Inc's book value per share is $2.29, while the current stock price is $13.84, resulting in a price-to-book (P/B) ratio of 6.05. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$27.20

96.53% upside potential

Analyst Recommendations

Strong Buy

1

Buy

4

Hold

0

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for TENX?
5 analysts cover TENX with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $27.20 implies 96.5% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on TENX?
Current analyst recommendations:1 Strong Buy, 4 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Mar 15, 2026, 02:19 AM

Technical Indicators

RSI (14-day)

62.77

Neutral

50-Day Moving Average

$13.13

5.41% above MA-50

200-Day Moving Average

$8.54

62.06% above MA-200

MACD Line

-0.24

MACD Signal

-0.36

MACD Histogram

0.13

Bullish

Q:What does TENX's RSI value tell investors?
The RSI (Relative Strength Index) for TENX is currently 62.77, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret TENX's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.24 above the signal line at -0.36, with histogram at 0.13. This bullish crossover suggests upward momentum is building. The 50-day MA ($13.13) is above the 200-day MA ($8.54), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Mar 11, 2026, 12:46 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for TENX and get notified when the price changes.

Stay Ahead of the Market with Tenax Therapeutics Inc Alerts

Set up price alerts for Tenax Therapeutics Inc and get notified instantly when the price hits your target. Never miss an important price movement again.